HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: study of 20 cases.

Abstract
Hemangiomas possess an extremely challenging treatment dilemma for surgeons and the patients. Most of the hemangiomas involute but if they don't involutes or impair the vital functions or occur in adults they need intervention. Present study was conducted to evaluate and discuss the response of sclerosing agent 3% sodium tetradecyl sulfate (STDS) in oral hemangioma. All 20 cases of hemangioma were diagnosed clinically and were treated with 3% sodium tetradecyl sulfate (STDS) injections locally at regular intervals depending upon the size of the lesion. Hemangioma regressed in all the cases with considerable relief of symptoms with minimal complications. When used in appropriate doses, Sclerosing agent, 3% sodium tetradecyl sulfate (STD), is very effective for treatment of oral hemangioma.
AuthorsSunita Agarwal
JournalIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India (Indian J Otolaryngol Head Neck Surg) Vol. 64 Issue 3 Pg. 205-7 (Sep 2012) ISSN: 2231-3796 [Print] India
PMID23998020 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: